1. Home
  2. ACHV vs FTH Comparison

ACHV vs FTH Comparison

Compare ACHV & FTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

N/A

Current Price

$6.80

Market Cap

726.5M

Sector

Health Care

ML Signal

N/A

Logo Faeth Therapeutics Inc. Common Stock

FTH

Faeth Therapeutics Inc. Common Stock

N/A

Current Price

$18.66

Market Cap

835.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ACHV
FTH
Founded
N/A
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
726.5M
835.7M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
ACHV
FTH
Price
$6.80
$18.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
15
Target Price
$14.15
★ $55.38
AVG Volume (30 Days)
★ 1.3M
345.2K
Earning Date
11-13-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.62
$16.57
52 Week High
$8.64
$42.14

Technical Indicators

Market Signals
Indicator
ACHV
FTH
Relative Strength Index (RSI) 44.06 33.59
Support Level $5.96 N/A
Resistance Level $7.30 $21.97
Average True Range (ATR) 0.38 2.11
MACD 0.04 0.14
Stochastic Oscillator 43.93 22.99

Price Performance

Historical Comparison
ACHV
FTH

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

About FTH Faeth Therapeutics Inc. Common Stock

Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.

Share on Social Networks: